Last reviewed · How we verify

NCT03396536

The Impact of Peri-implant Soft Tissue Properties on Patient-reported and Clinically Assessed Outcomes

Completed Last updated 12 March 2019
What this trial tests

trial testing Evaluation of KM in Keratinized Mucosa in 43 participants. Completed in 9 June 2015.

Timeline
15 January 2014
Primary endpoint
9 June 2015
9 June 2015

Quick facts

Lead sponsorTufts University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment43
Start date15 January 2014
Primary completion9 June 2015
Estimated completion9 June 2015

Drugs / interventions tested

Conditions studied

Sponsor

Tufts University

Who can join

18 and older, any sex, with Keratinized Mucosa. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to evaluate patient discomfort while performing oral hygiene (OH) around implants with and without keratinized mucosa (KM) and assess peri-implant soft tissue esthetic satisfaction and other clinical parameters at the 3- and 6-month follow-up visits. Group 1 will be implants with KM and Group 2 implants without KM. The hypotheses underlying this proposal are (1) that dental implants surrounded by KM will have better patient-reported outcomes regarding discomfort during brushing compared with those that lack KM; (2) that dental implants with KM will show more favorable clinical outcomes (plaque index, bleeding on probing, pocket depth and peri-implant recession) compared with those without KM and (3) that dental implants with KM will have higher patient peri-implant tissue esthetic satisfaction compared with those without KM.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Tufts University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03396536.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing